Long-term Effects of Aripiprazole Treatment during Adolescence on Cognitive Function and Dopamine D2 Receptor Expression in Neurodevelopmentally Normal Rats

키워드

참고문헌 (38)

1. Olfson M, "National trends in the office-based treatment of children, adolescents, and adults with antipsychotics", Arch Gen Psychiatry, 69, pp.1247~1256 (2012)
2. Olfson M, "Treatment of young people with antipsychotic medications in the United States", JAMA Psychiatry, 72, pp.867~874 (2015)
3. Correll CU, "Developments in pediatric psychopharmacology : focus on stimulants, antidepressants, and antipsychotics", J Clin Psychiatry, 72, pp.655~670 (2011)
4. Correll CU, "Antipsychotic use in youth without psychosis : a double-edged sword", JAMA Psychiatry, 72, pp.859~860 (2015)
5. Bardgett ME, "Adult rats treated with risperidone during development are hyperactive", Exp Clin Psychopharmacol, 21, pp.259~267 (2013)
6. Vinish M, "Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function", Int J Neuropsychopharmacol, 16, pp.1599~1609 (2013)
7. Milstein JA, "Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function", PLoS One, 8, pp.e57308~ (2013)
8. Moran-Gates T, "Effects of risperidone on dopamine receptor subtypes in developing rat brain", Eur Neuropsychopharmacol, 17, pp.448~455 (2007)
9. Xu S, "Olanzapine antipsychotic treatment of adolescent rats causes long term changes in glutamate and GABA levels in the nucleus accumbens", Schizophr Res, 161, pp.452~457 (2015)
10. Burris KD, "Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors", J Pharmacol Exp Ther, 302, pp.381~389 (2002)
11. Kirino E, "Efficacy and safety of aripiprazole in child and adolescent patients", Eur Child Adolesc Psychiatry, 21, pp.361~368 (2012)
12. Dawe GS, "Antipsychotic drugs dose-dependently suppress the spontaneous hyperactivity of the chakragati mouse", Neuroscience, 171, pp.162~172 (2010)
13. Renard J, "Long-term consequences of adolescent cannabinoid exposure in adult psychopathology", Front Neurosci, 8, pp.361~ (2014)
14. Semple BD, "Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species", Prog Neurobiol, 106-107, pp.1~16 (2013)
15. Lian J, "Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats", Pharmacol Rep, 68, pp.1028~1035 (2016)
16. De Santis M, "Early antipsychotic treatment in juvenile rats elicits long-term alterations to the dopamine neurotransmitter system", Int J Mol Sci, 17, pp.1944~ (2016)
17. De Santis M, "Early antipsychotic treatment in childhood", adolescent period has long-term effects on depressive-like, anxiety-like and locomotor behaviours in adult rats, 2016, pp.30, 204~214
18. Choi YK, "Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats", Eur Neuropsychopharmacol, 20, pp.187~194 (2010)
19. Natesan S, "Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors : comparing aripiprazole to other antipsychotics in animal models", Neuropsychopharmacology, 31, pp.1854~1863 (2006)
20. Reagan-Shaw S, "Dose translation from animal to human studies revisited", FASEB J, 22, pp.659~661 (2008)
21. Sestakova N, "Determination of motor activity and anxiety-related behaviour in rodents : methodological aspects and role of nitric oxide", Interdiscip Toxicol, 6, pp.126~135 (2013)
22. Moon SJ, "Effect of atomoxetine on hyperactivity in an animal model of attention-deficit", hyperactivity disorder(ADHD), 2014, pp.9, e108918~
23. Lalonde R, "The neurobiological basis of spontaneous alternation", Neurosci Biobehav Rev, 26, pp.91~104 (2002)
24. Thompson BL, "Prenatal cocaine exposure specifically alters spontaneous alternation behavior", Behav Brain Res, 164, pp.107~116 (2005)
25. Xu H, "Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D(1)and D(2)receptors in the caudate putamen of C57BL", 6 mouse, 2012, pp.91, 322~328
26. Burda K, "Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats", Pharmacol Rep, 63, pp.898~907 (2011)
27. Ratajczak P, "Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period", Pharmacol Rep, 65, pp.30~43 (2013)
28. 이봉주, "Effect of Aripiprazole on Cognitive Function and Hyperprolactinemia in Patients with Schizophrenia Treated with Risperidone", Clinical Psychopharmacology and Neuroscience, 11(2), pp.60~66 (2013), 대한정신약물학회
29. Kim SW, "Effectiveness of switching to aripiprazole from atypical antipsychotics in patients with schizophrenia", Clin Neuropharmacol, 32, pp.243~249 (2009)
30. Riedel M, "Effect of aripiprazole on cognition in the treatment of patients with schizophrenia", Pharmacopsychiatry, 43, pp.50~57 (2010)
31. -raclopride PET study with aripiprazole, "Transl Psychiatry", 2018, 87~
32. FDG imaging study with aripiprazole, "Psychopharmacology (Berl)", 2013, 221~229
33. Wahlstrom D, "Developmental changes in dopamine neurotransmission in adolescence : behavioral implications and issues in assessment", Brain Cogn, 72, pp.146~159 (2010)
34. Moran-Gates T, "Repeated antipsychotic drug exposure in developing rats : dopamine receptor effects", Synapse, 59, pp.92~100 (2006)
35. Li Z, "Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain", Eur J Pharmacol, 493, pp.75~83 (2004)
36. Spellman T, "Hippocampal-prefrontal input supports spatial encoding in working memory", Nature, 522, pp.309~314 (2015)
37. Wilkerson A, "Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats", Neuroscience, 89, pp.743~749 (1999)
38. Druzin MY, "The effects of local application of D2 selective dopaminergic drugs into the medial prefrontal cortex of rats in a delayed spatial choice task", Behav Brain Res, 109, pp.99~111 (2000)

관련 논문AI추천